Literature DB >> 21743710

Buprenorphine withdrawal syndrome.

B M Tripathi1, P Hemaraj, N K Dhar.   

Abstract

The increasing use of buprenorphine among drug dependent subjects demands systematic enquiry into the clinical profile of buprenorphine withdrawal. Six male buprenorphine dependent (parenteral) subjects were observed for opiate withdrawal over a two week period. The onset of withdrawal occurred 48 hours after the last dose, peaked around the third day and lasted up to ten days. The withdrawals were similar to morpliine type drugs and moderate in intensity.

Entities:  

Keywords:  buprenorphine; morpliine; opiate withdrawal

Year:  1995        PMID: 21743710      PMCID: PMC2970944     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  11 in total

1.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

2.  Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal.

Authors:  P J Fudala; J H Jaffe; E M Dax; R E Johnson
Journal:  Clin Pharmacol Ther       Date:  1990-04       Impact factor: 6.875

3.  Opioid antagonist challenges in buprenorphine maintained patients.

Authors:  T R Kosten; J H Krystal; D S Charney; L H Price; C H Morgan; H D Kleber
Journal:  Drug Alcohol Depend       Date:  1990-02       Impact factor: 4.492

4.  Role of opioid antagonists in treating intravenous cocaine abuse.

Authors:  T R Kosten; H D Kleber; C Morgan
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

5.  A case of buprenorphine abuse.

Authors:  A J Quigley; D E Bredemeyer; S S Seow
Journal:  Med J Aust       Date:  1984-03-31       Impact factor: 7.738

6.  Two new rating scales for opiate withdrawal.

Authors:  L Handelsman; K J Cochrane; M J Aronson; R Ness; K J Rubinstein; P D Kanof
Journal:  Am J Drug Alcohol Abuse       Date:  1987       Impact factor: 3.829

7.  A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.

Authors:  W K Bickel; M L Stitzer; G E Bigelow; I A Liebson; D R Jasinski; R E Johnson
Journal:  Clin Pharmacol Ther       Date:  1988-01       Impact factor: 6.875

8.  Buprenorphine as new treatment for heroin dependence.

Authors:  M Reisinger
Journal:  Drug Alcohol Depend       Date:  1985-12       Impact factor: 4.492

9.  Buprenorphine: a new maintenance opiate?

Authors:  S S Seow; A J Quigley; K F Ilett; L J Dusci; G Swensen; A Harrison-Stewart; L Rappeport
Journal:  Med J Aust       Date:  1986-04-14       Impact factor: 7.738

10.  Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.

Authors:  L San; J Camí; T Fernández; J M Ollé; J M Peri; M Torrens
Journal:  Br J Addict       Date:  1992-01
View more
  2 in total

1.  Opiate withdrawal syndrome in buprenorphine abusers admitted to a rehabilitation center in Tunisia.

Authors:  Ines Derbel; Asma Ghorbel; Férièle Messadi Akrout; Abdelmajid Zahaf
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

2.  Characterizing opioid withdrawal during double-blind buprenorphine detoxification.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Mollie E Miller; Paul A Nuzzo; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2015-03-12       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.